Jericho Assisted Living
Thursday, February 2, 2017
PCSK9 Inhibitor Delivers Key CV Benefits in First Outcomes Trial
(MedPage Today) -- Positive topline results announced for FOURIER
via
PCSK9 Inhibitor Delivers Key CV Benefits in First Outcomes Trial
by
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment